Ledger.Open graph →
SEC Form D · filed April 26, 2021

Neurexis Therapeutics, Inc

Offering
$57K
Sold
$50K
Exemption
Rule 506(b)
Industry
Other
Location
AURORA, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David Weiss, M.D · Cooper City, FLDirectorMichael C. Artinger · Fayetteville, ARExec · DirectorDaniel D. Mavico · Charlotte, NCExec · DirectorUlrich C. Bayer · Fayetteville, ARDirectorGregory D. Jackson · Harrisburg, PAExec · DirectorUlrich C. Bayer · Fayetteville, ARDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗